8. How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future success with Paul Ward - a podcast by Tom Caravela

My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success.

 

In this episode:

• How interviews are being conducted during this time
• Considering the travel bans and limited access, what other activities should MSLs be focusing on during the pandemic?
• Skills mandatory for MSLs during and after the crisis to find success
• How has COVID 19 affected the hiring landscape and what is expected to happen in the upcoming months/year
• How will HCP expectations change as a result of Covid
• How an MSL can meet or exceed expectations during the pandemic
• How does Paul expect Pharma to change practices as a result of Covid-19
• The advice Paul can give to MSLs to help aid in their success

 

Paul Ward

Further episodes of MSL Talk

Further podcasts by Tom Caravela

Website of Tom Caravela